Management of Refractory Constipation

First-Line Escalation: Add Stimulant Laxatives

The National Comprehensive Cancer Network recommends adding a stimulant laxative, such as senna 2-3 tablets twice to three times daily, titrated up to effect, with a goal of achieving one non-forced bowel movement every 1-2 days, when polyethylene glycol and fiber fail to produce a bowel movement after 3 days 1, 2
The evidence strongly supports adding stimulant laxatives rather than continuing the same approach when polyethylene glycol and fiber fail to produce a bowel movement after 3 days 3, 4

Senna can be started with 2-3 tablets twice to three times daily, and can be titrated up to 8-12 tablets per day maximum if needed, as recommended by the guidelines 2
Bisacodyl can be used at a dose of 10-15 mg orally 2-3 times daily or as a rectal suppository, as recommended by the National Comprehensive Cancer Network 1, 2
Magnesium-based products, such as magnesium hydroxide 30-60 mL daily or magnesium citrate 8 oz daily, can be used for rapid bowel evacuation, as recommended by the guidelines 1, 2, 3

The guidelines recommend continuing polyethylene glycol at 17 grams with 8 oz of water twice daily while adding the stimulant laxative, as this combination approach is more effective than either agent alone 1, 2

The National Comprehensive Cancer Network guidelines explicitly state that supplemental medicinal fiber is ineffective and may worsen constipation, and therefore should not be added 1
Fiber supplements like psyllium are ineffective for refractory constipation and may actually worsen the situation, particularly if the patient has inadequate fluid intake or underlying motility issues 1, 5, 2

Lactulose can be used at a dose of 15-30 mL twice daily as an osmotic laxative with a 2-3 day latency before effect, as recommended by the guidelines 3, 4
Sodium picosulfate can be used as an alternative stimulant laxative for short-term use in refractory cases, as recommended by the guidelines 3, 4
Rectal interventions, such as bisacodyl suppository or sodium phosphate/saline enema, can be used if oral agents continue to fail, as recommended by the National Comprehensive Cancer Network 1, 5

The guidelines recommend assessing for bowel obstruction, fecal impaction, or other secondary causes before aggressive escalation, and looking for signs such as abdominal distention, severe cramping, or vomiting 1, 5
Hard stool on digital rectal exam suggests impaction requiring manual disimpaction or enema, as recommended by the guidelines 5
Medications that worsen constipation, such as opioids, anticholinergics, and calcium channel blockers, should be considered, as recommended by the National Comprehensive Cancer Network 1, 2

Small volume enemas, such as sodium phosphate or saline, can be self-administered, but have contraindications such as neutropenia, thrombocytopenia, recent pelvic surgery or radiation, severe colitis, and undiagnosed abdominal pain, as recommended by the guidelines 5
The risk of perforation, rectal bleeding, and bacteremia should be considered when using enemas, as recommended by the guidelines 5

The National Comprehensive Cancer Network guidelines explicitly state that docusate sodium has not shown benefit and should not be used, as studies demonstrate that adding docusate to senna is less effective than senna alone 1, 2, 6

The guidelines recommend assessing response after 2-4 days of adding stimulant laxatives, with a goal of one non-forced bowel movement every 1-2 days 1, 2, 6
If no response is seen, reassess for obstruction and consider rectal interventions or prokinetic agents, as recommended by the National Comprehensive Cancer Network 1, 6

Prokinetic agents, such as prucalopride, can be used for chronic constipation when other laxatives have failed, as recommended by the guidelines 3, 4
Linaclotide is FDA-approved for idiopathic constipation, as recommended by the National Comprehensive Cancer Network 1
Methylnaltrexone or naloxegol can be used if opioid-induced constipation is suspected, as recommended by the guidelines 1, 3, 4